Cornelia de Lange syndrome
Cornelia de Lange syndrome (CdLS) is a genetic disorder. People with this syndrome experience a range of physical, cognitive, and medical challenges ranging from mild to severe. The syndrome has a widely varied phenotype, meaning people with the syndrome have varied features and challenges. The typical features of CdLS include thick or long eyebrows, a small nose, small stature, developmental delay, long or smooth philtrum, thin upper lip and downturned mouth.<ref name=":1">Hennekam, Raoul C.,
Diagnosis and management of Cornelia de Lange syndrome: first international consensus statement, Nature Reviews Genetics, Vol. 19(Issue: 10), pp. 649–666, DOI: 10.1038/s41576-018-0031-0, PMID: 29995837, Full text,</ref>

The syndrome is named after Dutch pediatrician Cornelia Catharina de Lange, who described it in 1933.
It is often termed Brachmann de Lange syndrome or Bushy syndrome and is also known as Amsterdam dwarfism. Its exact incidence is unknown, but it is estimated at 1 in 10,000 to 30,000.
Signs and symptoms
The phenotype of CdLS is highly varied and is described as a spectrum; from Classic CdLS (with a greater number of key features) to mild variations with only a few features. Some people will have a small number of features but don't have CdLS.<ref name=":1" />
Key features:
- Long and/or thick eyebrows
- Short nose
- Concave nasal ridge and/or upturned nasal tip
- Long and/or smooth philtrum
- Thin upper lip vermilion and/or downturned corners of mouth
- Missing fingers or toes
- Congenital diaphragmatic hernia
Other suggestive features:
- Developmental delay and/or intellectual disability
- Small prenatal and birth size / weight
- Small stature
- Microcephaly (prenatally and/or postnatally)
- Small hands and/or feet
- Short fifth finger
- Hirsutism
The following health conditions are more common in people with CdLS than in the general population.
- Respiratory illness
- Heart defects (e.g., pulmonary stenosis, VSD, ASD, coarctation of the aorta)
- Hearing impairment
- Vision abnormalities (e.g., ptosis, nystagmus, high myopia, hypertropia)
- Partial joining of the second and third toes
- Incurved 5th fingers (clinodactyly)
- Gastroesophageal reflux
- Gastrointestinal abnormalities
- Musculoskeletal problems
- Scoliosis
- Social anxiety
- Seizures
- Cleft palate
- Feeding problems
Children with this syndrome are often found to have long eyelashes, bushy eyebrows and synophrys (joined eyebrows). Body hair can be excessive and affected individuals are often shorter than their immediate family members. They present a characteristic facial phenotype.<ref>,
Recognition of the Cornelia de Lange syndrome phenotype with facial dysmorphology novel analysis, Clinical Genetics, 2016, Vol. 89(Issue: 5), pp. 557–563, DOI: 10.1111/cge.12716, PMID: 26663098,</ref>
Children with CdLS often suffer from gastrointestinal tract difficulties, particularly gastroesophageal reflux. Vomiting, intermittent poor appetite, constipation, diarrhea or gaseous distention are known to be a regularity in cases where the GI tract problems are acute. Symptoms may range from mild to severe.
People with CdLS may exhibit behaviours that have been described as "autistic-like," including self-stimulation, aggression, self-injury or strong preference to a structured routine. Behavior problems in CdLS are not inevitable. Many behaviour issues associated with CdLS are reactive (i.e., something happens within the person's body or environment to bring on the behavior) and cyclical (comes and goes). Often, an underlying medical issue, pain, social anxiety, environmental or caregiver stress can be associated with a change behaviour. If pain or a medical issue is the cause, once treated, the behaviour diminishes.
There is evidence for some features of premature aging including the early development of Barrett’s esophagus, osteoporosis present in the teenage years, premature greying of hair and some changes to the skin of the face causing a more aged appearance compared to chronological age.<ref name="pmid17640042">,
Natural history of aging in Cornelia de Lange syndrome, Am J Med Genet C Semin Med Genet, 2007, Vol. 145C(Issue: 3), pp. 248–60, DOI: 10.1002/ajmg.c.30137, PMID: 17640042, PMC: 4902018,</ref>
Causes
The vast majority of cases are thought to be due to spontaneous genetic mutations.<ref name=":1" /> It can be associated with mutations affecting the cohesin complex.<ref name="pmid19793304">,
Bushy Syndrome, cohesin, and beyond, Clin. Genet., Vol. 76(Issue: 4), pp. 303–14, DOI: 10.1111/j.1399-0004.2009.01271.x, PMID: 19793304, PMC: 2853897,</ref>
As of 2018, it was confirmed that 500 genetic mutations have been associated with the condition; occurring on 7 different genes. In around 30% of cases of CdLS the genetic cause remains undiscovered. The wide variation in phenotype is attributed to a high degree of somatic mosaicism in CdLS as well as the different genes and type of mutations. For this reason people with CdLS can have very different appearance, abilities, and associated health issues.<ref name=":0">Kline, Antonie D.,
Diagnosis and management of Cornelia de Lange syndrome: first international consensus statement, Nature Reviews Genetics, Vol. 19(Issue: 10), pp. 649–666, DOI: 10.1038/s41576-018-0031-0, PMID: 29995837, Full text,</ref>
| Name | OMIM | Gene | Appx. % | Notes |
|---|---|---|---|---|
| CDLS1 | 122470 | NIPBL | 50% | A gene responsible for CdLS on chromosome 5 was discovered in 2004 jointly by researchers at the Children's Hospital of Philadelphia, USA<ref>,
Cornelia de Lange syndrome is caused by mutations in NIPBL, the human homolog of Drosophila melanogaster Nipped-B, Nature Genetics, 2004, Vol. 36(Issue: 6), pp. 631–5, DOI: 10.1038/ng1364, PMID: 15146186, PMC: 4902017,</ref> and researchers at Newcastle University, UK.<ref>, NIPBL, encoding a homolog of fungal Scc2-type sister chromatid cohesion proteins and fly Nipped-B, is mutated in Cornelia de Lange syndrome, Nature Genetics, 2004, Vol. 36(Issue: 6), pp. 636–641, DOI: 10.1038/ng1363, PMID: 15146185,</ref> |
| CDLS2 | 300590 | SMC1A | 5% | In 2006, a second gene, on the X chromosome, was found by Italian scientists. |
| CDLS3 | 610759 | SMC3 | 1% | A third gene discovery was announced in 2007. The gene is on chromosome 10 and was also discovered by the research team in Philadelphia. |
The latter two genes seem to correlate with a milder form of the syndrome.
In 2004, researchers at the Children's Hospital of Philadelphia (United States) and the University of Newcastle upon Tyne (England) identified a gene (NIPBL) on chromosome 5 that causes CdLS when it is mutated. Since then, additional genes have been found (SMC1A, SMC3 and HDAC8, RAD21) that cause CdLS when changed. In July 2012, the fourth "CdLS gene"—HDAC8—was announced. HDAC8 is an X-linked gene, meaning it is located on the X chromosome. Individuals with CdLS who have the gene change in HDAC8 make up just a small portion of all people with CdLS.<ref name="CdLS Foundation - HDAC8 FAQ Sheet">
HDAC8 FAQ Sheet(link). {{{website}}}. Cornelia de Lange Syndrome Foundation.
</ref> Evidence of a linkage at chromosome 3q26.3 is mixed.<ref name="pmid11391654">,
Exclusion of linkage to the CDL1 gene region on chromosome 3q26.3 in some familial cases of Cornelia de Lange syndrome, American Journal of Medical Genetics, Vol. 101(Issue: 2), pp. 120–9, DOI: <120::AID-AJMG1319>3.0.CO;2-G 10.1002/1096-8628(20010615)101:2<120::AID-AJMG1319>3.0.CO;2-G, PMID: 11391654, PMC: 4896160,</ref>
Genetic alterations associated with CdLS have been identified in genes NIPBL, SMC1A and SMC3 as well as the more recently identified genes RAD21 and HDAC8.<ref name="pmid25209348">,
Cornelia de Lange syndrome, Clin. Genet., 2015, Vol. 88(Issue: 1), pp. 1–12, DOI: 10.1111/cge.12499, PMID: 25209348,</ref> All of these genetic alterations occurring in CdLS patients affect proteins that function in the cohesin pathway.<ref name="pmid25209348" /> SMC1A, SMC3 and RAD21 proteins are structural components of the cohesin ring complex. NIPBL is involved in the loading of the cohesin ring onto chromosomes, and HDAC8 deacylates SMC3 to facilitate its function. The cohesin pathway is involved in cohesion of sister chromatids during mitosis, DNA repair, chromosome segregation and the regulation of developmental gene expression. Defects in these functions are theorised to underlie some of the features of CdLS.<ref name="pmid20358602">, Mutations and variants in the cohesion factor genes NIPBL, SMC1A, and SMC3 in a cohort of 30 unrelated patients with Cornelia de Lange syndrome, Am. J. Med. Genet. A, 2010, Vol. 152A(Issue: 4), pp. 924–9, DOI: 10.1002/ajmg.a.33348, PMID: 20358602, PMC: 2923429,</ref> In particular, defective DNA repair may underlie the features of premature aging.<ref name="pmid17640042" />
Diagnosis
The diagnosis of CdLS is primarily based on clinical findings by a clinical geneticist; and in some cases may be confirmed through laboratory testing.<ref name=":0" />
Treatment
Often, an interdisciplinary approach is recommended to treat the issues associated with CdLS. A team for promoting the child's well-being often includes speech, occupational and physical therapists, teachers, physicians, and parents.<ref name="CdLS Foundation"> ,
CdLS Foundation – Treatment Protocols Full text, , 12 February 2013,
</ref>
History
The first documented case was in 1916 by Winfried Robert Clemens Brachmann (1888–1969), a German physician who wrote about the distinct features of the disease from his 19-year-old patient,<ref>,
Ein Fall von symmetrischer Monodaktylie durch Ulnadefekt, mit symmetrischer Flughautbildung in den Ellenbeugen, sowie anderen Abnormitaeten (Zwerghaftigkeit, Halsrippen, Behaarung) (A case of symmetrical monodactyly, representing ulnar deficiency, with symmetrical antecubital webbing and other abnormalities, (dwarfism, cervical ribs, hirsutism)), Jahrbuch fuer Kinderheilkunde und physische Erziehung, 1916, Vol. 84, pp. 225–235,</ref> followed in 1933 by Cornelia Catharina de Lange (1871–1950),<ref>, Sur un type nouveau de degenerescence (typus Amstelodamensis), Arch. Med. Enfants, 1933, Vol. 36, pp. 713–719,</ref> a Dutch pediatrician after whom the disorder has been named.<ref>
Brachmann-de Lange syndrome(link). {{{website}}}.
</ref> CdLS was formerly known as Brachmann-de Lange Syndrome.<ref name=AtoZ>,
A-Z of Genetic Factors in Autism: A Handbook for Professionals. online version, London:Jessica Kingsley, ISBN 9781843109761, Pages: 172–173,</ref>
This section needs additional citations for verification. (September 2016) |
References
<references group="" responsive="1"></references>
External links
Ad. Transform your life with W8MD's Budget GLP-1 injections from $75


W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Weight loss injections in NYC (generic and brand names):
- Zepbound / Mounjaro, Wegovy / Ozempic, Saxenda
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $75 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointmentsNYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian


